Stock Events

Stock Events

Diagnos 

€0.16
5
-€0-0.63% Wednesday 06:07

Statistics

Day High
0.16
Day Low
0.16
52W High
0.22
52W Low
0.1
Volume
-
Avg. Volume
-
Mkt Cap
7.78M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-4,140.46%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
135,070.33Revenue
-5.59MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4D4A.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Idexx Laboratories
IDXX
Mkt Cap45.35B
IDEXX Laboratories provides diagnostic and IT products for animal health, competing in the broader diagnostic market similar to Diagnos.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers a wide range of diagnostics products, including rapid diagnostics and laboratory diagnostics, directly competing with Diagnos' offerings.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific provides analytical instruments, reagents and consumables, and software services, competing in the diagnostics and research market.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation operates in the diagnostics sector, offering a broad portfolio of healthcare products that compete with Diagnos' diagnostic solutions.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories offers clinical diagnostics and life science research products, directly competing in the diagnostics market.
Labcorp
LH
Mkt Cap22.69B
Laboratory Corporation of America Holdings provides comprehensive clinical laboratory and end-to-end drug development services, competing in the diagnostics and healthcare service market.
Quest Diagnostics
DGX
Mkt Cap22.03B
Quest Diagnostics offers diagnostic testing, information, and services, directly competing with Diagnos in the diagnostics market.
Hologic
HOLX
Mkt Cap16.89B
Hologic specializes in diagnostics, medical imaging systems, and surgical products, competing in the women's health diagnostic market which overlaps with Diagnos' focus areas.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market.
Bruker
BRKR
Mkt Cap5.6B

About

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Show more...
CEO
ISIN
CA2524423068
WKN
000A2PH0N

Listings

F
DE
4D4A.F
OTC Link
US
DGNOF
V
CA
ADK.V

0 Comments

Share your thoughts

FAQ

What is Diagnos stock price today?▼
The current price of 4D4A.F is €0.16 EUR — it has decreased by -0.63% in the past 24 hours. Watch Diagnos stock price performance more closely on the chart.
What is Diagnos stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Diagnos stocks are traded under the ticker 4D4A.F.
Is Diagnos stock price growing?▼
4D4A.F stock has fallen by -0.63% compared to the previous week, the month change is a -11.67% fall, over the last year Diagnos has showed a +1.92% increase.
What is Diagnos market cap?▼
Today Diagnos has the market capitalization of 7.78M
When is the next Diagnos earnings date?▼
Diagnos is going to release the next earnings report on June 04, 2026.
What is Diagnos revenue for the last year?▼
Diagnos revenue for the last year amounts to 135,070.33 EUR.
What is Diagnos net income for the last year?▼
4D4A.F net income for the last year is -5.59M EUR.
When did Diagnos complete a stock split?▼
The last stock split for Diagnos was on April 24, 2019 with a ratio of 1:10.